Editor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGESApple ( AAPL) estimates, target increased at Citigroup. Shares of AAPL now seen reaching $450. Estimates also raised on stronger than expected iPhone demand. Buy rating. Apple ( AAPL) estimates raised at UBS through 2012. Strong iPad2 sales and higher gross margins. Maintain $510 price target and Buy rating. Amgen ( AMGN) estimates, target changed at UBS. Shares of AMGN now seen reaching $58. Estimates were increased on potential Prolia acceleration. Neutral rating. Campbell Soup ( CPB) estimates changed at UBS. CPB estimates were raised through 2011, but lowered for 2012. Company has positive recovery plan, but ongoing negative volume trends. $36 price target and Neutral rating. Diodes ( DIOD) estimates, target lowered at UBS. Shares of DIOD now seen reaching $27, according to UBS. Estimates also lowered on limited potential for near term margin expansion. Neutral rating. Electronic Arts ( ERTS) estimates upped at BMO through 2013. Company increased its guidance. Outperform rating and $28 price target. Electronic Arts ( ERTS) estimates, target raised at UBS. Shares of ERTS now seen reaching $27, according to UBS. Estimates also raised, as company acquires casual game development studio PopCap . Buy rating. Fastenal ( FAST) estimates, target boosted at Credit Suisse. Shares of FAST now seen reaching $39, according to Credit Suisse. Estimates also upped, given improving business momentum. Neutral rating. Gilead Sciences ( GILD) estimates lowered at UBS through 2012. Updated model reflects prescription trends and pricing changes. Maintain $47 price target and Buy rating. Infosys ( INFY) estimates increased at Oppenheimer through 2013. Industry demand trends should remain strong. Perform rating. KAR Auction ( KAR) target raised at Goldman. Shares of KAR now seen reaching $18. Salvage business is improving. Neutral rating. LAM Research ( LRCX) estimates, target cut at UBS. Shares of LRCX now seen reaching $55. Estimates also lowered to reflect more conservative near term trends. Maintain Buy rating. Nasdaq OMX ( NDAQ) estimates, target cut at Jefferies. Shares of NDAQ now seen reaching $27. Estimates also lowered as near term M&A activity appears unlikely. Maintain Hold rating.